$167 Million is the total value of Cambridge Financial Group, Inc.'s 30 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RTN | Exit | Raytheon Co | $0 | – | -62,475 | -100.0% | -3.18% | – |
FDX | Exit | Fedex Corp | $0 | – | -36,000 | -100.0% | -3.27% | – |
BIIB | Exit | BIOGEN IDEC INC | $0 | – | -16,391 | -100.0% | -3.53% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Target Corp | 39 | Q3 2023 | 4.3% |
Sysco Corp | 39 | Q3 2023 | 5.9% |
Cardinal Health | 39 | Q3 2023 | 5.0% |
UnitedHealth Group | 37 | Q4 2022 | 4.5% |
ARCHER DANIELS MIDLAND CO | 35 | Q4 2021 | 3.7% |
WALGREENS BOOTS ALLIANCE INC | 33 | Q3 2023 | 3.8% |
Oneok | 32 | Q3 2023 | 5.4% |
Microsoft Corporation | 28 | Q3 2023 | 5.0% |
Ryder System | 28 | Q3 2023 | 4.5% |
MCDONALDS CORP | 27 | Q3 2023 | 4.1% |
View Cambridge Financial Group, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-13 |
13F-HR | 2024-02-06 |
13F-HR | 2023-11-13 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-07 |
13F-HR | 2022-05-09 |
13F-HR | 2022-02-11 |
13F-HR | 2021-10-29 |
13F-HR | 2021-08-13 |
13F-HR | 2021-05-07 |
View Cambridge Financial Group, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.